- Status:
- Red
- Decision Date:
- August 2022
Comments
Treatment of adults with von Hippel-Lindau (VHL) disease. Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
search again